Tailored Treatment to Enhance Risk Perception in Sleep Apnea

NACompletedINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

October 1, 2014

Primary Completion Date

April 30, 2020

Study Completion Date

March 31, 2021

Conditions
Obstructive Sleep Apnea (OSA)
Interventions
BEHAVIORAL

Brief Personalized Video (BPV)

The BPV group will view a portion of their own sleep study that took place during their overnight sleep study.

BEHAVIORAL

Non-Personalized Video (NPV)

The NPV group will see a stock video of someone with OSA.

BEHAVIORAL

Treatment as Usual (TAU)

The TAU group will not watch a video.

Trial Locations (1)

80206

National Jewish Health, Denver

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

National Jewish Health

OTHER

NCT02314858 - Tailored Treatment to Enhance Risk Perception in Sleep Apnea | Biotech Hunter | Biotech Hunter